Skip to main content
Back
Watch Compare

SeaStar Medical Holding Corp

Data quality: 100%
Also listed as ICUCW Nasdaq
ICU
Nasdaq Manufacturing Measuring & Analyzing Instruments
$4.11
▼ $0.07 (-1.67%)
Mkt Cap: 16.41 M
Price
$4.11
Mkt Cap
16.41 M
Day Range
$4.02 — $4.28
52-Week Range
$2.07 — $13.50
Volume
64,089
Open $4.18
50D / 200D Avg
$2.63
56.49% above
50D / 200D Avg
$4.90
16.06% below

Quick Summary

Key Takeaways

Negative free cash flow of -13.60 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)814.07%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-164.13%
Below sector avg (-51.02%)
ROIC-129.93%
Net Margin-984.60%
Op. Margin-986.63%

Safety

Debt / Equity
N/A
Current Ratio3.66
Interest Coverage-392.74

Valuation

PE (TTM)
-1.35
Above sector avg (-1.98)
P/B Ratio1.43
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -1.4 -2.0
P/B 1.4 5.1
ROE % -164.1 -51.0
Net Margin % -984.6 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 814.07% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.23 M Net Income (TTM) -12.15 M
ROE -164.13% ROA -101.62%
Gross Margin 95.71% Operating Margin -986.63%
Net Margin -984.60% Free Cash Flow (TTM) -13.60 M
ROIC -129.93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.66
Interest Coverage -392.74 Asset Turnover 0.10
Working Capital 10.81 M Tangible Book Value 11.46 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.35 Forward P/E N/A
P/B Ratio 1.43 P/S Ratio 13.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -82.85%
Market Cap 16.41 M Enterprise Value 16.41 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.31
FCF / Share -3.41 OCF / Share -3.41
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 111.93%
SBC-Adj. FCF -14.35 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.23 M 135,000.0 — — —
Net Income -12.15 M -24.83 M -26.23 M -23.01 M 75,317.0
EPS (Diluted) — -6.63 -1.21 -2.80 —
Gross Profit 1.18 M 135,000.0 — — —
Operating Income -12.18 M -17.84 M -14.21 M -11.61 M -1.12 M
EBITDA — — — — —
R&D Expenses 7.52 M 9.11 M 5.97 M 2.82 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 31,000.0 244,000.0 1.08 M 630,000.0 —
Income Tax 3,000.0 3,000.0 0.0 1,000.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 14.16 M 4.66 M 3.51 M 4.77 M 105.93 M
Total Liabilities 3.74 M 6.84 M 17.38 M 13.00 M 10.93 M
Shareholders' Equity 10.42 M -2.18 M -13.87 M -8.24 M -10.57 M
Total Debt — 4.14 M 4.14 M — —
Cash & Equivalents — — — — 51,567.0
Current Assets 13.58 M 3.77 M 2.31 M 3.04 M —
Current Liabilities 3.74 M 6.84 M 13.05 M 5.35 M 376,702.0